Company Profile
Curis Inc Stock Price, News & Analysis
Company overview
Business overview
Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Curis is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Curis follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Curis sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
CRIS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Curis’s catalysts are oncology and immunotherapy pipeline updates, plus any strategic step that clarifies what still has value. The company needs a cleaner development path to matter again.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
Curis Provides Fourth Quarter 2025 Business Update
Source: Curis Inc
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.